Aperio Group, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2020$1,358,000
+6.6%
79,921
+4.1%
0.00%0.0%
Q3 2020$1,274,000
-24.7%
76,804
+5.2%
0.00%
-33.3%
Q2 2020$1,692,000
+59.5%
73,038
+22.9%
0.01%
+20.0%
Q1 2020$1,061,000
+9.0%
59,405
+31.8%
0.01%
+66.7%
Q4 2019$973,000
+42.9%
45,082
+20.6%
0.00%0.0%
Q3 2019$681,000
-56.5%
37,380
-15.2%
0.00%
-50.0%
Q2 2019$1,567,000
+14.5%
44,069
+8.3%
0.01%0.0%
Q1 2019$1,368,000
+13.2%
40,709
+10.8%
0.01%0.0%
Q4 2018$1,208,000
-47.7%
36,730
-3.1%
0.01%
-40.0%
Q3 2018$2,310,000
+17.7%
37,898
-5.7%
0.01%
+11.1%
Q2 2018$1,963,000
-65.8%
40,194
-25.5%
0.01%
-69.0%
Q1 2018$5,736,000
+92.7%
53,985
+8.3%
0.03%
+93.3%
Q4 2017$2,976,000
+185.1%
49,830
+14.6%
0.02%
+150.0%
Q3 2017$1,044,000
+23.3%
43,485
+0.3%
0.01%
+20.0%
Q2 2017$847,000
-7.6%
43,347
+11.0%
0.01%
-16.7%
Q1 2017$917,000
+100.7%
39,057
+4.7%
0.01%
+100.0%
Q4 2016$457,000
-36.0%
37,305
-10.2%
0.00%
-40.0%
Q3 2016$714,000
+85.9%
41,553
+53.9%
0.01%
+66.7%
Q2 2016$384,000
+0.5%
27,004
-2.9%
0.00%0.0%
Q1 2016$382,000
-22.8%
27,814
-5.4%
0.00%
-40.0%
Q4 2015$495,000
+121.0%
29,395
+43.5%
0.01%
+150.0%
Q3 2015$224,000
+28.0%
20,483
+46.4%
0.00%0.0%
Q2 2015$175,00013,9880.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2015
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders